Regulation detail

F-Tag F697

Up to date
Ask Ariadne
SR
F-Tag F697 active

§483.25(k) Pain Management.

Jurisdiction: CM Agency: Centers for Medicare & Medicaid Services
SNF (100%)
Plain-English summary

This regulation (F-Tag F697) requires nursing homes to provide individualized pain management to residents who need it, consistent with professional standards of practice, each resident's comprehensive person-centered care plan, and the resident's own goals and preferences. Facilities must assess pain at admission and on an ongoing basis, develop and implement both non-pharmacological and pharmacological interventions, monitor effectiveness and adverse consequences, and revise care plans as needed. Special attention is required for residents with opioid use disorder, cognitive impairment, or those receiving end-of-life care. Surveyors cite deficiencies when facilities fail to recognize pain, provide adequate treatment, or align care with resident preferences.

View official source
Regulation text
F697
(Rev. 229; Issued: 04-25-25; Effective: 04-25-25; Implementation: 04-28-25) 
 
§483.25(k) Pain Management. 
 
The facility must ensure that pain management is provided to residents who require 
such services, consistent with professional standards of practice, the comprehensive 
person-centered care plan, and the residents’ goals and preferences. 
 
INTENT 
 
Based on the comprehensive assessment of a resident, the facility must ensure that 
residents receive the treatment and care in accordance with professional standards of 
practice, the comprehensive care plan, and the resident’s choices, related to pain 
management. 
 
DEFINITIONS 
 
“Acute Pain” refers to pain that is usually sudden in onset and time-limited with a 
duration of less than 1 month and often is caused by injury, trauma, or medical treatments 
such as surgery. (From the Centers for Disease Control and Prevention
 (CDC)). 
 
“Adjuvant Medication” refers to any medication with a primary indication other than 
pain management but with analgesic properties in some painful conditions.2 

“Adverse Consequence” refers to an unpleasant symptom or event that is due to or 
associated with a medication, such as impairment or decline in a resident’s mental or 
physical condition or functional or psychosocial status. It may include various types of 
adverse drug reactions and interactions (e.g., medication-medication, medication-food, 
and medication-disease). 
 
“Chronic Pain” refers to pain that typically lasts greater than 3 months and can be the 
result of an underlying medical disease or condition, injury, medical treatment, 
inflammation, or unknown cause. (From the CDC
). 
 
"Medication Assisted Treatment” (MAT) refers to the use of medications, in 
combination with counseling and behavioral therapies
, to provide a “whole-patient” 
approach to the treatment of substance use disorders. (From the Substance Abuse and 
Mental Health Services Administration (SAMHSA)). 
 
"Opioid Use Disorder" (OUD) refers to a problematic pattern of opioid use leading to 
clinically significant impairment or distress. Additional criteria used to assess and 
diagnose OUD can be found in the Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition (DSM-5). 
 
“Subacute Pain” refers to pain that has been present for 1–3 months. (From the CDC
). 
 
NOTE: Adverse drug reaction (ADR) is a form of adverse consequences. It may be 
either a secondary effect of a medication that is usually undesirable and different from the 
therapeutic effect of the medication or any response to a medication that is noxious and 
unintended and occurs in doses for prophylaxis, diagnosis, or treatment. The term “side 
effect” is often used interchangeably with ADR; however, side effects are but one of five 
ADR categories, the others being hypersensitivity, idiosyncratic response, toxic reactions, 
and adverse medication interactions. A side effect is an expected, well-known reaction 
that occurs with a predictable frequency and may or may not constitute an adverse 
consequence. 
 
GUIDANCE 
Recognition and Management of Pain - In order to help a resident, attain or maintain 
his or her highest practicable level of well-being and to prevent or manage pain, the 
facility, to the extent possible: 
 
• Recognizes when the resident is experiencing pain and identifies circumstances 
when pain can be anticipated; 
 
• Evaluates the existing pain and the cause(s), and 
 
• Manages or prevents pain, consistent with the comprehensive assessment and plan 
of care, current professional standards of practice, and the resident’s goals and 
preferences. 

Overview of Pain Recognition and Management 
 
Nursing home residents are at high risk for having pain that may affect function, impair 
mobility, impair mood, or disturb sleep, and diminish quality of life. It is important, 
therefore, that a resident’s reports of pain, or nonverbal signs suggesting pain, be 
evaluated. The resident’s needs and goals as well as the etiology, type, and severity of 
pain are relevant to developing a plan for pain management. It should be noted that while 
analgesics can reduce pain and enhance the quality of life, they do not necessarily address 
the underlying cause of pain. It is important to consider treating the underlying cause, 
where possible. 
 
Strategies for Pain Management 
Strategies for the prevention and management of pain may include but are not limited to 
the following: 
• Assessing the potential for pain, recognizing the onset, presence and duration of 
pain, and assessing the characteristics of the pain; 
 
• Addressing/treating the underlying causes of the pain, to the extent possible; 
 
• Developing and implementing both non-pharmacological and pharmacological 
interventions/approaches to pain management, depending on factors such as 
whether the pain is episodic, continuous, or both; 
 
• Identifying and using specific strategies for preventing or minimizing different 
levels or sources of pain or pain-related symptoms based on the resident-specific 
assessment, preferences and choices, a pertinent clinical rationale, and the 
resident’s goals and; using pain medications judiciously to balance the resident’s 
desired level of pain relief with the avoidance of unacceptable adverse 
consequences; 
 
• Monitoring appropriately for effectiveness and/or adverse consequences (e.g., 
constipation, sedation) including defining how and when to monitor the resident’s 
symptoms and degree of pain relief; and 
 
• Modifying the approaches, as necessary. 
 
Use of Opioids for Pain Management—Prescribing practitioners may find that opioid 
medications are the most appropriate treatment for acute pain, subacute pain, and chronic 
pain in some residents. Opioid treatment for pain needs to be appropriately assessed and 
individualized for each resident. However, because of increasing opioid addiction, abuse, 
and overdoses, prescribers should use caution when prescribing opioids, and consider 
using alternative pain management approaches, when appropriate. When opioids are 
used, the lowest possible effective dosage should be prescribed for the shortest amount of 
time possible after considering all medical needs and the resident should be monitored for 

effectiveness and any adverse effects. When starting opioid therapy for acute, subacute, 
or chronic pain, clinicians may consider prescribing immediate-release opioids instead of 
extended-release and long-acting. 
 
Due to the risk of fatal respiratory depression, combining opioids and benzodiazepines 
should be avoided unless clinically indicated for an individual resident. Risks related to 
combining these medications are even greater for adults aged 65 and older and include 
falls and hip fractures, cognitive impairment/confusion, daytime fatigue, and delirium. If 
concurrent use of opioids and benzodiazepines is clinically indicated for an individual 
resident, the resident should be closely monitored for adverse consequences. 
 
Medication regimens for residents receiving end of life, palliative, or hospice care may 
include opioids alone or combining opioids and benzodiazepines; their use must be 
consistent with accepted standards of practice for this specialty of care. 
 
When treating pain in a resident with an addiction history or opioid use disorder (OUD), 
strategies must be used to relieve pain while also considering the OUD or addiction 
history. These strategies may include continuation of medication assisted treatment 
(MAT), if appropriate, non-opioid pain medications, and non-pharmacological 
approaches. 
 
NOTE: Requirements at 483.10(c)(5) describe the resident’s right to be informed of the 
risks and benefits of the proposed treatment. For concerns related to informing the 
resident or resident representative of the risks of opioid use for pain, refer to F552. 
 
For additional information, refer to: 
 
• Exposure-Response Association Between Concurrent Opioid and Benzodiazepine 
Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries, 
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2685628
. 
• National Institute on Drug Abuse Benzodiazepines and Opioids, 
https://nida.nih.gov/research-topics/opioids/benzodiazepines-opioids
 
• Geriatricpain.org, Resources and Tools for Quality Pain Care, 
https://geriatricpain.org/
 
• The Society for Post-Acute and Long-Term Care Medicine (AMDA) opioid The 
Society for Post-Acute and Long-Term Care Medicine (AMDA) 
Opioids in 
Nursing Homes , https://paltc.org/opioids%20in%20nursing%20homes 
• Centers for Disease Control Clinical Practice Guidelines for Prescribing Opioids 
for Pain https://www.cdc.gov/opioids/patients/guideline.html 
 
Pain Recognition 
 
Because pain can significantly affect a person’s well-being, it is important that the facility 
recognize and address pain promptly. The facility’s evaluation of the resident at 
admission and during ongoing assessments helps identify the resident who is 
experiencing pain or for whom pain may be anticipated during specific procedures, care, 

or treatment. In addition, it is important that a resident be monitored for the presence of 
pain and be evaluated when there is a change in condition and whenever new pain or an 
exacerbation of pain is suspected. As with many symptoms, pain in a resident with 
moderate to severe cognitive impairment may be more difficult to recognize and assess.

Expressions of pain may be verbal or nonverbal and are subjective. A resident may avoid 
the use of the term “pain.” Other words used to report or describe pain may differ by 
culture, language and/or region of the country. Examples of descriptions may include 
heaviness or pressure, stabbing, throbbing, hurting, aching, gnawing, cramping, burning, 
numbness, tingling, shooting or radiating, spasms, soreness, tenderness, discomfort, pins 
and needles, feeling “rough,” tearing or ripping. Verbal descriptions of pain can help a 
practitioner identify the source, nature, and other characteristics of the pain. Nonverbal 
indicators which may represent pain need to be viewed in the entire clinical context with 
consideration given to pain as well as other clinically pertinent explanations. Examples of 
possible indicators of pain include, but are not limited to the following: 
 
• Negative verbalizations and vocalizations (e.g., groaning, crying/whimpering, or 
screaming); 
• Facial expressions (e.g., grimacing, frowning, fright, or clenching of the jaw); 
 
• Changes in gait (e.g., limping), skin color, vital signs (e.g., increased heart rate, 
respirations and/or blood pressure), perspiration; 
 
• Behavior such as resisting care, distressed pacing, irritability, depressed mood, or 
decreased participation in usual physical and/or social activities; 
 
• Loss of function or inability to perform Activities of Daily Living (ADLs) (e.g., 
rubbing a specific location of the body, or guarding a limb or other body parts); 
 
• Difficulty eating or loss of appetite; and 
 
• Difficulty sleeping (insomnia). 
 
In addition to the pain item sections of the MDS, many sections such as sleep cycle, 
change in mood, decline in function, instability of condition, weight loss, and skin 
conditions can be potential indicators of pain. Any of these findings may indicate the 
need for additional and more thorough evaluation. 
 
Many residents have more than one active medical condition and may experience pain 
from several different causes simultaneously. Many medical conditions may be painful 
such as pressure injuries, diabetes with neuropathic pain, immobility, amputation, post- 
CVA, venous and arterial ulcers, multiple sclerosis, oral health conditions, and infections. 
In addition, common procedures, such as moving a resident or performing physical or 
occupational therapies or changing a wound dressing may be painful. Understanding the 
underlying causes of pain is an important step in determining optimal approaches to 
prevent, minimize, or manage pain. 

Observations at rest and during movement, particularly during activities that may 
increase pain (such as dressing changes, exercises, turning and positioning, bathing, 
rising from a chair, walking) can help to identify whether the resident is having pain. 
Observations during eating or during the provision of oral hygiene may also indicate 
dental, mouth and/or facial pain. 
 
Recognizing the presence of pain and identifying those situations where pain may be 
anticipated involves the participation of health care professionals and direct care and 
ancillary staff who have contact with the resident. Information may be obtained by 
talking with the resident, directly examining the resident, and observing the resident’s 
behavior. Staffing consistency and familiarity with the residents has a significant effect 
on the staff’s ability to identify and differentiate pain-related behavior from other 
behavior of cognitively impaired residents. 
 
Nursing assistants may be the first to notice a resident’s symptoms; therefore, it is 
important that they are able to recognize a change in the resident and the resident’s 
functioning and to report the changes to a nurse for follow-up. Family members or 
friends may also recognize and report when the resident experiences pain and may 
provide information about the resident’s pain symptoms, pain history and previously 
attempted interventions. Other staff, e.g., dietary, activities, therapy, housekeeping, who 
have direct contact with the resident may also report changes in resident behavior or 
resident complaints of pain. 
 
Assessment 
 
In addition to the Resident Assessment Instrument (RAI), it is important that the facility 
identifies how they will consistently assess pain. Some facilities may use assessment 
tools that are appropriate for use with their resident population. There are many reliable 
and valid evidenced based practice tools available to facility staff to assist in the 
assessment of pain. Pain assessment tools that can be used with cognitively intact and 
impaired residents can be obtained on the Geriatric Pain website at 
https://geriatricpain.org/clinicians/pain-assessment-information
. 
 
An assessment or an evaluation of pain based on professional standards of practice may 
necessitate gathering the following information, as applicable to the resident: 
 
• History of pain and its treatment (including non-pharmacological and 
 
• pharmacological treatment and whether or not each treatment has been effective); 

• History of addiction, past and/or ongoing and related treatment for OUD; 
 
• Characteristics of pain, such as: (intensity, pattern, location, frequency and 
duration) 

• Impact of pain on quality of life (e.g., sleeping, functioning, appetite, and mood); 
 
• Factors such as activities, care, or treatment that precipitate or exacerbate pain as 
well as those that reduce or eliminate the pain; 
 
• Additional symptoms associated with pain (e.g., nausea, anxiety); 
 
• Physical and psychosocial issues (physical examination of the site of the pain, 
 
• movement, or activity that causes the pain, as well as any discussion with resident 
about any psychological or psychosocial concerns that may be causing or 
exacerbating the pain); 

• Current medical conditions and medications including medication assisted 
treatment for OUD; and 
 
• The resident’s goals for pain management and his or her satisfaction with the 
current level of pain control. 
 
While it may be difficult to conduct a thorough assessment of all of the above factors in a 
cognitively impaired or non-responsive resident, the facility staff is responsible for 
obtaining as much information as possible and evaluating the resident’s pain through all 
available means. Observing the resident during care, activities, and treatments helps not 
only to detect whether pain is present, but also to potentially identify its location and the 
limitations it places on the resident. 
 
Management of Pain 
 
Based on the evaluation, the facility, in collaboration with the attending 
physician/prescriber, other health care professionals, and the resident and/or his/her 
representative, develops, implements, monitors and revises as necessary interventions to 
prevent or manage each individual resident’s pain, beginning at admission. These 
interventions may be integrated into components of the comprehensive care plan, 
addressing conditions or situations that may be associated with pain, or may be included 
as a specific pain management need or goal. 
 
The interdisciplinary team and the resident and/or representative collaborate to arrive at 
pertinent, realistic and measurable goals for treatment, such as reducing pain sufficiently 
to allow the resident to ambulate comfortably to the dining room for each meal or to 
participate in 30 minutes of physical therapy. Depending on the situation and the 
resident’s wishes, the target may be to reduce the pain level, but not necessarily to 
become pain-free. To the extent possible, the interdisciplinary team educates the resident 
and/or representative about the need to report pain when it occurs and about the various 
approaches to pain management and the need to monitor the effectiveness of the 

interventions used. 
 
The basis for effective interventions includes several considerations, such as the 
resident’s needs and goals; the source(s), type and severity of pain (recognizing that the 
resident may experience pain from one or more sources either simultaneously or at 
different times) and awareness of the available treatment options. Often, sequential trials 
of various treatment options are needed to develop the most effective approach. 
 
It is important for pain management approaches to follow pertinent professional 
standards of practice and to identify who is to be involved in managing the pain and 
implementing the care or supplying the services (e.g., facility staff, such as RN, LPN, 
CNA; attending physician or other practitioner; certified hospice; or other contractors 
such as therapists). Pertinent current professional standards of practice may provide 
recommended approaches to pain management even when the cause cannot be or has not 
been determined. 
 
Non-pharmacological interventions 
 
Research supports physical activity and exercise as a part of most treatment programs for 
chronic pain. Activity can be supported by conventional physical therapy and exercise 
approaches, or by a wide range of movement therapies. 
 
Some non-pharmacologic interventions may need to be ordered by the provider while 
others can be provided by facility staff during routine care. Examples of non-
pharmacological interventions may include, but are not limited to: 
 
• Altering the environment for comfort (such as adjusting room temperature, 
tightening and smoothing linens, using pressure redistributing mattress and 
positioning, comfortable seating, and assistive devices); 
 
• Physical modalities, such as ice packs or cold compresses (to reduce swelling and 
lessen sensation), mid heat (to decrease joint stiffness and increase blood flow to 
an area), neutral body alignment and repositioning, baths, transcutaneous 
electrical nerve stimulation (TENS), massage, acupuncture/acupressure, 
chiropractic, or rehabilitation therapy; 
 
• Exercises to address stiffness and prevent contractures as well as restorative 
nursing programs to maintain joint mobility; and 
 
• Cognitive/Behavioral interventions (e.g., relaxation techniques, reminiscing, 
diversions, activities, music therapy, offering spiritual support and comfort, as 
well as teaching the resident coping techniques and education about pain). 
 
Pharmacological interventions 

The interdisciplinary team (nurses, practitioner, pharmacists, etc.) is responsible for 
developing a pain management regimen that is specific to each resident who has pain or 
who has the potential for pain, such as during a treatment. The regimen considers factors 
such as the causes, location, and severity of the pain, the potential benefits, risks and 
adverse consequences of medications; and the resident’s desired level of relief and 
tolerance for adverse consequences. The resident may accept partial pain relief in order 
to experience fewer significant adverse consequences (e.g., desire to stay alert instead of 
experiencing drowsiness/confusion). The interdisciplinary team works with the resident 
to identify the most effective and acceptable route for the administration of analgesics, 
such as orally, rectally, topically, by injection, by infusion pump, and/or transdermally. 
 
It is important to follow a systematic approach for selecting medications and doses to 
treat pain. Developing an effective pain management regimen may require repeated 
attempts to identify the right interventions. General guidelines for choosing appropriate 
categories of medications in various situations are widely available to the provider, 
pharmacist and nurses. 

Factors influencing the selection and doses of medications include the resident’s medical 
condition, current medication regimen, nature, severity, and cause of the pain and the 
course of the illness. Analgesics may help manage pain; however, they often do not 
address the underlying cause of pain. Examples of different approaches may include, but 
are not limited to: administering lower doses of medication initially and titrating the dose 
slowly upward, administering medications “around the clock” rather than “on demand” 
(PRN); or combining longer acting medications with PRN medications for breakthrough 
pain. Recurrent use of or repeated requests for PRN medications may indicate the need 
to reevaluate the situation, including the current medication regimen. Some clinical 
conditions or situations may require using several analgesics and/or adjuvant medications 
(e.g., antidepressants or anticonvulsants) together. Documentation helps to clarify the 
rationale for a treatment regimen and to acknowledge associated risks. 
 
Opioids or other potent analgesics have been used for residents who are actively dying, 
those with complex pain syndromes, and those with more severe acute or chronic pain 
that has not responded to non-opioid analgesics or other measures. Opioids should be 
selected and dosed in accordance with current professional standards of practice and 
manufacturers’ guidelines in order to optimize their effectiveness and minimize their 
adverse consequences. Adverse consequences may be especially problematic when the 
resident is receiving other medications with significant effects on the cardiovascular and 
central nervous systems. Therefore, careful titration of dosages based on 
monitoring/evaluating the effectiveness of the medication and the occurrence of adverse 
consequences is necessary. The clinical record should reflect the ongoing 
communication between the prescriber and the staff is necessary for the optimal and 
judicious use of pain medications. 
 
Other interventions have been used for some residents with more advanced, complex, or 
poorly controlled pain such as radiation therapy, neurostimulation, spinal delivery of 
analgesics (implanted catheters and pump systems), and neurolytic procedures (chemical 

or surgical) that are administered under the close supervision of expert practitioners. 
Referrals to pain management clinics and pain management specialists may also be 
appropriate in these situations. 
 
Monitoring, Reassessment, and Care Plan Revision 
 
Monitoring the resident over time helps identify the extent to which pain is controlled, 
relative to the individual’s goals and the availability of effective treatment. The ongoing 
evaluation of the status (presence, increase or reduction) of a resident’s pain is vital, 
including the status of underlying causes, the response to interventions to prevent or 
manage pain, and the possible presence of adverse consequences of treatment. Adverse 
consequences related to analgesics can often be anticipated and to some extent prevented 
or reduced. For example, opioids routinely cause constipation, which may be minimized 
by an appropriate bowel regimen. 
 
Identifying target signs and symptoms (including verbal reports and non-verbal indicators 
from the resident) and using standardized assessment tools can help the interdisciplinary 
team evaluate the resident’s pain and responses to interventions and determine whether 
the care plan should be revised, for example: 
 
• If pain has not been adequately controlled, it may be necessary to reconsider the 
current approaches and revise or supplement them as indicated; or 
 
• If pain has resolved or there is no longer an indication or need for pain 
medication, the facility works with the practitioner to discontinue or taper (as 
needed to prevent withdrawal symptoms) analgesics. 
 
Additionally, a facility should evaluate whether there is a time or day pattern to a 
resident’s reports or signs of increased pain to ensure that the problem is not due to drug 
diversion. 
 
The CDC describes a number of side effects which prescription opioids can cause even 
when given as directed. Some side effects for which residents should be monitored 
include: 
 
• Tolerance, meaning more medication may be needed to achieve the same level of 
pain relief; 
 
• Physical dependence which causes symptoms of withdrawal when opioid 
medication is stopped, or a dose is held or missed; 
 
• Increased sensitivity to pain; 
 
• Constipation; 
 
• Nausea, vomiting, and dry mouth; 

• Sleepiness, dizziness, and/or confusion; 
 
• Depression; and 
 
• Itching and sweating. 
 
According to the Substance Abuse and Mental Health Administration (SAMHSA), opioid 
overdose deaths can be prevented by administering naloxone, a medication approved by 
the Food and Drug Administration to reverse the effects of opioids. The United States 
Surgeon General has recommended that naloxone be kept on hand where there is a risk 
for an opioid overdose. Facilities should have a written policy to address opioid 
overdoses. 
 
The SAMHSA website houses a number of resources related to opioid management 
including this document intended for prescribers which addresses appropriate prescribing, 
monitoring for adverse effects, and treating overdoses: SAMHSA Opioid Overdose 
Prevention Toolkit: 
Information for Prescribers, 
https://www.samhsa.gov/resource/ebp/opioid-overdose-
prevention-toolkit. 
 
For concerns related to staff monitoring for adverse effects of opioid use, see F757, 
Unnecessary Medications. 
 
INVESTIGATIVE PROCEDURES 
 
Use the Pain Recognition and Management Critical Element (CE) Pathway, along with 
the above interpretive guidelines, when determining if the facility provides pain 
management that meets professional standards of practice; and that is in accordance with 
the resident’s comprehensive care plan, goals for care and preferences. 
 
Briefly review the most recent comprehensive assessments, comprehensive care plan and 
orders to identify whether the facility has assessed and developed an individualized care 
plan based on professional standards of practice and provided by qualified, competent 
staff. During this review, identify the extent to which the facility has implemented 
interventions in accordance with the resident’s needs, goals for care and professional 
standards of practice, consistently across all shifts. This information will guide 
observations and interviews to be made in order to corroborate concerns identified. 
 
NOTE: Always observe for visual cues of psychosocial distress and harm (see Guidance 
on Severity and Scope Levels and Psychosocial Outcome Severity Guide). 
 
KEY ELEMENTS OF NONCOMPLIANCE 
 
To cite deficient practice at F697, the surveyor's investigation will generally show that 
the facility failed to do any one or more of the following: 

• Provide pain management to a resident experiencing pain; or 
 
• Provide pain management that met professional standards of practice; or 
 
• Provide pain management that was in accordance with the resident’s 
comprehensive care plan, and the resident’s goals for care and preferences. 

DEFICIENCY CATEGORIZATION 
 
An example of Level 4, immediate jeopardy to resident health or safety includes, but 
is not limited to: 
 
• Facility failed to implement an effective pain management regime for a resident 
who sustained a fracture of the hip and was determined to not be a surgical 
candidate. Resident stated that pain medication was not effective, and she was in 
continuous pain. She indicated she had notified staff of the pain, but nothing was 
done. Interview of staff indicated no one had contacted the practitioner to discuss 
the ineffective pain relief. The staff stated that they were concerned regarding the 
amount of pain medication the resident was receiving and that they were 
concerned that she would become increasingly tolerant and addicted to the 
medication. They stated they were aware that the resident declined assistance with 
ADL’s due to “pain” and felt that the resident was not having the amount of pain 
that she stated she had. The resident was observed on multiple occasions to, 
holding her hip area, moaning and crying out, sweating, and striking out when 
staff attempted to move her. 
 
An example of Level 3, actual harm that is not immediate jeopardy includes, but is 
not limited to: 
 
• The facility failed to provide effective pain management to a resident with a 
diagnosis of bone cancer. Record review revealed the resident only had PRN (as 
needed) pain medication every six hours. According to the resident this pain 
regime was not effective resulting in excruciating breakthrough pain multiple 
times each day. The resident said that staff would tell her she had to wait, and 
often would not get the PRN medicine promptly when it was due. The surveyor 
observed the resident to be tearful and unable to participate in activities. 
 
Examples of Level 2, no actual harm, with potential for more than minimal harm, 
that is not immediate jeopardy includes, but is not limited to: 
 
• Facility failed to provide an effective pain management treatment per the 
resident’s choice and preference. A resident request a hot shower on the evening 
shift as an effective intervention for back pain. The staff member assigned to her 
informed her that she would not be able to be showered until later in the evening. 

A staff member who understood what the resident was experiencing quickly 
intervened and gave her a hot shower relieving her back pain. 
 
• The facility staff failed to consistently evaluate the effectiveness of regularly 
scheduled pain medication on a resident. The resident was receiving the pain 
medication on a routine basis; however, the record did not reflect the resident’s 
response to the administration of the pain medication. In interviews, the resident 
stated that her pain was being managed for the most part, but that staff did not ask 
her if she received relief from the medication. She stated that occasionally, she 
would not attend an activity due to discomfort, but this did not routinely occur. 
When she mentioned it to staff, they would tell her to lie down for a while and 
would check on her later. However, she stated that they usually did not recheck 
her. Staff interviewed stated they didn’t have the time to go back, check, and 
record the resident’s response, but, if she complained, they would recheck her and 
see if she needed anything else. 
 
Level 1, no actual harm with potential for minimal harm: 
The failure of the facility to provide appropriate care and services related to pain 
management places the resident at risk for more than minimal harm. Therefore Severity 
1 does not apply for this regulatory requirement.